Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Century Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 57 | 2 | 47 | −8 |
| Shares | 20.3M | 18.9K | 25.7M | +5.43M (+26.8%) |
| Value | $10.1M | $9.43K | $25.6M | +$15.5M (+153.0%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Century Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 5,961,631 | $5.93M | 0.01% |
| Adage Capital Partners GP, L.L.C. | 1,838,700 | $1.83M | 0.00% |
| Spruce Street Capital LP | 1,421,532 | $1.41M | 0.47% |
| Algert Global LLC | 76,800 | $76.4K | 0.00% |
| Scientech Research LLC | 12,355 | $12.3K | 0.01% |
| Simplex Trading, LLC | 2,397 | $2.38K | 0.00% |
| Wells Fargo & Company | 40 | $40 | 0.00% |
| Smartleaf Asset Management LLC | 1 | $1 | 0.00% |
Sold out (16)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,538,609 | $1.76M |
| Tang Capital Management LLC | 900,000 | $448.2K |
| Squarepoint Ops LLC | 236,053 | $117.6K |
| Goldman Sachs Group Inc | 60,682 | $30.2K |
| Marshall Wace, LLP | 54,161 | $27.1K |
| Bluefin Capital Management, LLC | 24,018 | $12.0K |
| HRT Financial LP | 18,113 | $9.00K |
| Qube Research & Technologies Ltd | 17,501 | $8.71K |
| Tower Research Capital LLC (TRC) | 13,116 | $6.53K |
| Jain Global LLC | 11,241 | $5.60K |
| AQR Capital Management LLC | 10,660 | $5.31K |
| Advisory Services Network, LLC | 407 | $203 |
| Morgan Stanley | 118 | $59 |
| EverSource Wealth Advisors, LLC | 28 | $14 |
| IFP Advisors, Inc | 6 | $3 |
| CWM, LLC | 254 | $0 |
Not filed for Q4 2025 yet (2)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asia (Singapore) Pte. Ltd. | 17,861 | $8.89K |
| Point72 (DIFC) Ltd | 1,064 | $530 |